GPR119 agonists (Merck & Co)

N/A

Report date: 2025/03/20 15:28:16
NME

Base Information

Drug NameGPR119 agonists (Merck & Co)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonists
TargetsGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsHypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A